Molecular Templates announces C-suite reshuffle: interim CMO, President/CFO, COO, CSO

Molecular Templates, Inc.

Roger Waltzman resigns as CMO effective Aug 4, 2023; no disagreement cited.
Gabriela Gruia appointed interim CMO; $471,960 base salary, option for 175k shares.
Jason Kim named President and CFO, formalizing his interim CFO role.
Kristen Quigley named COO; Grace Kim named Chief Strategy Officer and Head of IR.
Board appoints Harold Selick to Audit Committee, Corsee Sanders to Nominating Committee.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jason S. Kim

Chief Financial Officer

Molecular Templates, Inc.

Effective: 2023-08-01
Filed: August 2, 2023, 7:59 PM ET

On August 1, 2023, the Board also appointed Jason S. Kim, the Company’s Interim Chief Financial Officer, as its Chief Financial Officer.

Departed

Roger Waltzman

Chief Medical Officer

Molecular Templates, Inc.

Effective: 2023-08-04
Successor: Gabriela Gruia
Filed: August 2, 2023, 7:59 PM ET

On July 27, 2023, Roger Waltzman, M.D. notified the Board of Directors (the “Board”) of Molecular Templates, Inc. (the “Company”) of his decision to resign from his position as Chief Medical Officer of the Company, effective as of August 4, 2023.

Appointed (interim)

Gabriela Gruia

Interim Chief Medical Officer

Molecular Templates, Inc.

Effective: 2023-08-01
Filed: August 2, 2023, 7:59 PM ET

On August 1, 2023, the Company appointed Gabriela Gruia, M.D. to serve as the Company’s interim Chief Medical Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason S. Kim was appointed as Chief Financial Officer at Molecular Templates, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On August 1, 2023, the Board also appointed Jason S. Kim, the Company’s Interim Chief Financial Officer, as its Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Roger Waltzman resigned as Chief Medical Officer at Molecular Templates, Inc..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On July 27, 2023, Roger Waltzman, M.D. notified the Board of Directors (the “Board”) of Molecular Templates, Inc. (the “Company”) of his decision to resign from his position as Chief Medical Officer of the Company, effective as of August 4, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gabriela Gruia was appointed as Interim Chief Medical Officer at Molecular Templates, Inc..

Action: appointed
Role: Interim Chief Medical Officer

Exact text from the filing

On August 1, 2023, the Company appointed Gabriela Gruia, M.D. to serve as the Company’s interim Chief Medical Officer.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-23-201733

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.